vix.ing · top · new · best · stats

Inflammation-associated lymphangiogenesis: a double-edged sword?

2014/03/03 by Honsoul Kim, Raghu P. Kataru, Gou Young Koh · 231 citations
Medicine · #Bioinformatics #Biology #Cancer #Cancer research #Immunology #Inflammation #Internal medicine #Lymphangiogenesis #Lymphatic System and Diseases #Lymphatic system #Medicine #Metastasis #Pathology #Pathophysiology #Sympathectomy and Hyperhidrosis Treatments #VEGF receptors #Vascular Malformations and Hemangiomas

paper · pdf · doi:10.1172/jci71607

published in Journal of Clinical Investigation 124(3), 936-942 (American Society for Clinical Investigation)

openalex publication_date 2014/03/03 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31

Abstract

Lymphangiogenesis and lymphatic vessel remodeling are complex biological processes frequently observed during inflammation. Accumulating evidence indicates that inflammation-associated lymphangiogenesis (IAL) is not merely an endpoint event, but actually a phenomenon actively involved in the pathophysiology of various inflammatory disorders. The VEGF-C/VEGFR-3 and VEGF-A/VEGF-R2 signaling pathways are two of the best-studied pathways in IAL. Methods targeting these molecules, such as prolymphangiogenic or antilymphatic treatments, were found to be beneficial in various preclinical and/or clinical studies. This Review focuses on the most recent achievements in the fields of lymphatic biology relevant to inflammatory conditions. Additionally, preclinical and clinical therapies that modulate IAL are summarized.

Cited by

Related